BraTS orchestrator : Democratizing and Disseminating state-of-the-art brain tumor image analysis
Authors:
Florian Kofler,
Marcel Rosier,
Mehdi Astaraki,
Ujjwal Baid,
Hendrik Möller,
Josef A. Buchner,
Felix Steinbauer,
Eva Oswald,
Ezequiel de la Rosa,
Ivan Ezhov,
Constantin von See,
Jan Kirschke,
Anton Schmick,
Sarthak Pati,
Akis Linardos,
Carla Pitarch,
Sanyukta Adap,
Jeffrey Rudie,
Maria Correia de Verdier,
Rachit Saluja,
Evan Calabrese,
Dominic LaBella,
Mariam Aboian,
Ahmed W. Moawad,
Nazanin Maleki
, et al. (12 additional authors not shown)
Abstract:
The Brain Tumor Segmentation (BraTS) cluster of challenges has significantly advanced brain tumor image analysis by providing large, curated datasets and addressing clinically relevant tasks. However, despite its success and popularity, algorithms and models developed through BraTS have seen limited adoption in both scientific and clinical communities. To accelerate their dissemination, we introdu…
▽ More
The Brain Tumor Segmentation (BraTS) cluster of challenges has significantly advanced brain tumor image analysis by providing large, curated datasets and addressing clinically relevant tasks. However, despite its success and popularity, algorithms and models developed through BraTS have seen limited adoption in both scientific and clinical communities. To accelerate their dissemination, we introduce BraTS orchestrator, an open-source Python package that provides seamless access to state-of-the-art segmentation and synthesis algorithms for diverse brain tumors from the BraTS challenge ecosystem. Available on GitHub (https://github.com/BrainLesion/BraTS), the package features intuitive tutorials designed for users with minimal programming experience, enabling both researchers and clinicians to easily deploy winning BraTS algorithms for inference. By abstracting the complexities of modern deep learning, BraTS orchestrator democratizes access to the specialized knowledge developed within the BraTS community, making these advances readily available to broader neuro-radiology and neuro-oncology audiences.
△ Less
Submitted 13 June, 2025;
originally announced June 2025.
